Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab in c-ANCA associated vasculitic polyneuropathy complicated by local peritonitis.

Literature DB >> 21573943

Rituximab in c-ANCA associated vasculitic polyneuropathy complicated by local peritonitis.

Jens Witsch, Werner Stenzel, Thilo Witsch, Johann Braun, George Trendelenburg.

Abstract

Entities: Chemical Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21573943 DOI： 10.1007/s00415-011-6090-1

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

× No keyword cloud information.

8 in total

1. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors: J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal: Arthritis Rheum Date: 2001-04

2. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors: John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245

3. Cyclophosphamide therapy in Wegener's granulomatosis.

Authors: S N Novack; C M Pearson
Journal: N Engl J Med Date: 1971-04-29 Impact factor: 91.245

Review 4. Guillain-Barré syndrome.

Authors: Richard A C Hughes; David R Cornblath
Journal: Lancet Date: 2005-11-05 Impact factor: 79.321

2 in total

Review 1. Progress in peripheral nerve disease research in the last two years.

Authors: Matthew Evans; Hadi Manji
Journal: J Neurol Date: 2013-10-25 Impact factor: 4.849

Review 2. Rituximab seems a promising therapeutic option in granulomatosis with polyangiitis with intestinal perforation: a case report and literature review.

Authors: Muhammet Sait Dag; Yavuz Pehlivan; Ediz Tutar; Bunyamin Kisacik
Journal: BMJ Case Rep Date: 2013-01-22

2 in total

Rituximab in c-ANCA associated vasculitic polyneuropathy complicated by local peritonitis.

1. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

2. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

3. Cyclophosphamide therapy in Wegener's granulomatosis.

Review 4. Guillain-Barré syndrome.

5. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.

6. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic.

7. Wegener granulomatosis: an analysis of 158 patients.

Review 8. The effect of chemotherapeutic agents on wound healing.

Review 1. Progress in peripheral nerve disease research in the last two years.

Review 2. Rituximab seems a promising therapeutic option in granulomatosis with polyangiitis with intestinal perforation: a case report and literature review.